ERBB2 and neoplasm: As expected, HER2-HER3 dimers were generally more frequent in BM classified as HER2+, but this was not a particularly reliable indicator, as some brain metastases had a high frequency of HER2-HER3 complexes regardless of HER2 status, and conversely, some tumours classified as HER2+ had relatively lower levels.